Annual CAPEX
$266.30 M
+$1.50 M+0.57%
31 December 2023
Summary:
Edwards Lifesciences annual capital expenditures is currently $266.30 million, with the most recent change of +$1.50 million (+0.57%) on 31 December 2023. During the last 3 years, it has fallen by -$141.00 million (-34.62%). EW annual CAPEX is now -34.62% below its all-time high of $407.30 million, reached on 31 December 2020.EW CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$57.30 M
-$28.10 M-32.90%
30 September 2024
Summary:
Edwards Lifesciences quarterly capital expenditures is currently $57.30 million, with the most recent change of -$28.10 million (-32.90%) on 30 September 2024. Over the past year, it has increased by +$2.00 million (+3.62%). EW quarterly CAPEX is now -49.52% below its all-time high of $113.50 million, reached on 31 December 2020.EW Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$316.30 M
+$2.00 M+0.64%
30 September 2024
Summary:
Edwards Lifesciences TTM capital expenditures is currently $316.30 million, with the most recent change of +$2.00 million (+0.64%) on 30 September 2024. Over the past year, it has increased by +$49.20 million (+18.42%). EW TTM CAPEX is now -26.63% below its all-time high of $431.10 million, reached on 31 March 2021.EW TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.6% | +3.6% | +18.4% |
| 3 y3 years | -34.6% | -5.6% | -9.5% |
| 5 y5 years | +10.2% | -24.7% | +19.6% |
EW CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -34.6% | +0.6% | -38.9% | +33.0% | -9.5% | +19.4% |
| 5 y | 5 years | -34.6% | +10.2% | -49.5% | +33.0% | -26.6% | +19.6% |
| alltime | all time | -34.6% | +602.6% | -49.5% | +716.1% | -26.6% | +3063.0% |
Edwards Lifesciences CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $57.30 M(-32.9%) | $316.30 M(+0.6%) |
| June 2024 | - | $85.40 M(+0.1%) | $314.30 M(+13.5%) |
| Mar 2024 | - | $85.30 M(-3.4%) | $277.00 M(+4.0%) |
| Dec 2023 | $266.30 M(+0.6%) | $88.30 M(+59.7%) | $266.30 M(-0.3%) |
| Sept 2023 | - | $55.30 M(+15.0%) | $267.10 M(-1.7%) |
| June 2023 | - | $48.10 M(-35.5%) | $271.70 M(+1.9%) |
| Mar 2023 | - | $74.60 M(-16.3%) | $266.70 M(+0.7%) |
| Dec 2022 | $264.80 M(-19.7%) | $89.10 M(+48.7%) | $264.80 M(-1.7%) |
| Sept 2022 | - | $59.90 M(+39.0%) | $269.50 M(-0.3%) |
| June 2022 | - | $43.10 M(-40.7%) | $270.30 M(-8.8%) |
| Mar 2022 | - | $72.70 M(-22.5%) | $296.50 M(-10.1%) |
| Dec 2021 | $329.80 M(-19.0%) | $93.80 M(+54.5%) | $329.80 M(-5.6%) |
| Sept 2021 | - | $60.70 M(-12.4%) | $349.50 M(-10.9%) |
| June 2021 | - | $69.30 M(-34.6%) | $392.10 M(-9.0%) |
| Mar 2021 | - | $106.00 M(-6.6%) | $431.10 M(+5.8%) |
| Dec 2020 | $407.30 M(+46.3%) | $113.50 M(+9.9%) | $407.30 M(+11.5%) |
| Sept 2020 | - | $103.30 M(-4.6%) | $365.30 M(+8.0%) |
| June 2020 | - | $108.30 M(+31.8%) | $338.10 M(+12.1%) |
| Mar 2020 | - | $82.20 M(+15.0%) | $301.60 M(+8.3%) |
| Dec 2019 | $278.40 M(+15.2%) | $71.50 M(-6.0%) | $278.40 M(+5.3%) |
| Sept 2019 | - | $76.10 M(+6.0%) | $264.50 M(-3.3%) |
| June 2019 | - | $71.80 M(+21.7%) | $273.50 M(+7.5%) |
| Mar 2019 | - | $59.00 M(+2.4%) | $254.50 M(+5.3%) |
| Dec 2018 | $241.70 M(+37.7%) | $57.60 M(-32.3%) | $241.70 M(-0.7%) |
| Sept 2018 | - | $85.10 M(+61.2%) | $243.40 M(+25.3%) |
| June 2018 | - | $52.80 M(+14.3%) | $194.20 M(-4.4%) |
| Mar 2018 | - | $46.20 M(-22.1%) | $203.10 M(+15.7%) |
| Dec 2017 | $175.50 M(-19.3%) | $59.30 M(+65.2%) | $175.50 M(-2.2%) |
| Sept 2017 | - | $35.90 M(-41.8%) | $179.40 M(-6.5%) |
| June 2017 | - | $61.70 M(+231.7%) | $191.80 M(-7.9%) |
| Mar 2017 | - | $18.60 M(-70.6%) | $208.30 M(-4.2%) |
| Dec 2016 | $217.40 M(+104.1%) | $63.20 M(+30.8%) | $217.40 M(+11.2%) |
| Sept 2016 | - | $48.30 M(-38.2%) | $195.50 M(+12.9%) |
| June 2016 | - | $78.20 M(+182.3%) | $173.20 M(+52.7%) |
| Mar 2016 | - | $27.70 M(-32.9%) | $113.40 M(+6.5%) |
| Dec 2015 | $106.50 M(+13.7%) | $41.30 M(+58.8%) | $106.50 M(-3.6%) |
| Sept 2015 | - | $26.00 M(+41.3%) | $110.50 M(+7.7%) |
| June 2015 | - | $18.40 M(-11.5%) | $102.60 M(+2.4%) |
| Mar 2015 | - | $20.80 M(-54.1%) | $100.20 M(+6.9%) |
| Dec 2014 | $93.70 M(-14.9%) | $45.30 M(+150.3%) | $93.70 M(+34.6%) |
| Sept 2014 | - | $18.10 M(+13.1%) | $69.60 M(-6.1%) |
| June 2014 | - | $16.00 M(+11.9%) | $74.10 M(-15.4%) |
| Mar 2014 | - | $14.30 M(-32.5%) | $87.60 M(-20.4%) |
| Dec 2013 | $110.10 M(-5.1%) | $21.20 M(-6.2%) | $110.10 M(-17.2%) |
| Sept 2013 | - | $22.60 M(-23.4%) | $133.00 M(-2.3%) |
| June 2013 | - | $29.50 M(-19.8%) | $136.10 M(+1.0%) |
| Mar 2013 | - | $36.80 M(-16.6%) | $134.80 M(+16.2%) |
| Dec 2012 | $116.00 M | $44.10 M(+71.6%) | $116.00 M(+12.3%) |
| Sept 2012 | - | $25.70 M(-8.9%) | $103.30 M(+6.4%) |
| June 2012 | - | $28.20 M(+56.7%) | $97.10 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $18.00 M(-42.7%) | $88.10 M(+4.5%) |
| Dec 2011 | $84.30 M(+33.8%) | $31.40 M(+61.0%) | $84.30 M(+13.0%) |
| Sept 2011 | - | $19.50 M(+1.6%) | $74.60 M(+4.3%) |
| June 2011 | - | $19.20 M(+35.2%) | $71.50 M(+5.1%) |
| Mar 2011 | - | $14.20 M(-34.6%) | $68.00 M(+7.9%) |
| Dec 2010 | $63.00 M(-1.6%) | $21.70 M(+32.3%) | $63.00 M(-3.1%) |
| Sept 2010 | - | $16.40 M(+4.5%) | $65.00 M(+7.1%) |
| June 2010 | - | $15.70 M(+70.7%) | $60.70 M(-2.3%) |
| Mar 2010 | - | $9.20 M(-61.2%) | $62.10 M(-3.0%) |
| Dec 2009 | $64.00 M(-17.9%) | $23.70 M(+95.9%) | $64.00 M(-24.7%) |
| Sept 2009 | - | $12.10 M(-29.2%) | $85.00 M(-0.1%) |
| June 2009 | - | $17.10 M(+54.1%) | $85.10 M(+6.4%) |
| Mar 2009 | - | $11.10 M(-75.2%) | $80.00 M(+2.6%) |
| Dec 2008 | $78.00 M(+24.8%) | $44.70 M(+266.4%) | $78.00 M(+50.9%) |
| Sept 2008 | - | $12.20 M(+1.7%) | $51.70 M(-6.3%) |
| June 2008 | - | $12.00 M(+31.9%) | $55.20 M(-4.8%) |
| Mar 2008 | - | $9.10 M(-50.5%) | $58.00 M(-7.2%) |
| Dec 2007 | $62.50 M(+5.2%) | $18.40 M(+17.2%) | $62.50 M(+1.6%) |
| Sept 2007 | - | $15.70 M(+6.1%) | $61.50 M(-3.6%) |
| June 2007 | - | $14.80 M(+8.8%) | $63.80 M(+1.4%) |
| Mar 2007 | - | $13.60 M(-21.8%) | $62.90 M(+5.9%) |
| Dec 2006 | $59.40 M(+16.5%) | $17.40 M(-3.3%) | $59.40 M(-10.5%) |
| Sept 2006 | - | $18.00 M(+29.5%) | $66.40 M(+12.2%) |
| June 2006 | - | $13.90 M(+37.6%) | $59.20 M(+7.4%) |
| Mar 2006 | - | $10.10 M(-58.6%) | $55.10 M(+8.0%) |
| Dec 2005 | $51.00 M(+20.0%) | $24.40 M(+125.9%) | $51.00 M(+10.2%) |
| Sept 2005 | - | $10.80 M(+10.2%) | $46.30 M(+6.7%) |
| June 2005 | - | $9.80 M(+63.3%) | $43.40 M(+2.1%) |
| Mar 2005 | - | $6.00 M(-69.5%) | $42.50 M(0.0%) |
| Dec 2004 | $42.50 M(+12.1%) | $19.70 M(+149.4%) | $42.50 M(+22.8%) |
| Sept 2004 | - | $7.90 M(-11.2%) | $34.60 M(+98.9%) |
| June 2004 | - | $8.90 M(+48.3%) | $17.40 M(-51.8%) |
| Mar 2004 | - | $6.00 M(-49.2%) | $36.10 M(-4.7%) |
| Dec 2003 | $37.90 M(-6.9%) | $11.80 M(-226.9%) | $37.90 M(-9.5%) |
| Sept 2003 | - | -$9.30 M(-133.7%) | $41.90 M(-29.8%) |
| June 2003 | - | $27.60 M(+253.8%) | $59.70 M(+46.0%) |
| Mar 2003 | - | $7.80 M(-50.6%) | $40.90 M(+0.5%) |
| Dec 2002 | $40.70 M(+7.1%) | $15.80 M(+85.9%) | $40.70 M(+17.0%) |
| Sept 2002 | - | $8.50 M(-3.4%) | $34.80 M(-2.2%) |
| June 2002 | - | $8.80 M(+15.8%) | $35.60 M(-1.7%) |
| Mar 2002 | - | $7.60 M(-23.2%) | $36.20 M(-4.7%) |
| Dec 2001 | $38.00 M(-17.4%) | $9.90 M(+6.5%) | $38.00 M(-3.1%) |
| Sept 2001 | - | $9.30 M(-1.1%) | $39.20 M(-10.5%) |
| June 2001 | - | $9.40 M(0.0%) | $43.80 M(-3.5%) |
| Mar 2001 | - | $9.40 M(-15.3%) | $45.40 M(-1.3%) |
| Dec 2000 | $46.00 M(+9.5%) | $11.10 M(-20.1%) | $46.00 M(+31.8%) |
| Sept 2000 | - | $13.90 M(+26.4%) | $34.90 M(+66.2%) |
| June 2000 | - | $11.00 M(+10.0%) | $21.00 M(+110.0%) |
| Mar 2000 | - | $10.00 M | $10.00 M |
| Dec 1999 | $42.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual capital expenditures?
- What is the all time high annual CAPEX for Edwards Lifesciences?
- What is Edwards Lifesciences annual CAPEX year-on-year change?
- What is Edwards Lifesciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly CAPEX year-on-year change?
- What is Edwards Lifesciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Edwards Lifesciences?
- What is Edwards Lifesciences TTM CAPEX year-on-year change?
What is Edwards Lifesciences annual capital expenditures?
The current annual CAPEX of EW is $266.30 M
What is the all time high annual CAPEX for Edwards Lifesciences?
Edwards Lifesciences all-time high annual capital expenditures is $407.30 M
What is Edwards Lifesciences annual CAPEX year-on-year change?
Over the past year, EW annual capital expenditures has changed by +$1.50 M (+0.57%)
What is Edwards Lifesciences quarterly capital expenditures?
The current quarterly CAPEX of EW is $57.30 M
What is the all time high quarterly CAPEX for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly capital expenditures is $113.50 M
What is Edwards Lifesciences quarterly CAPEX year-on-year change?
Over the past year, EW quarterly capital expenditures has changed by +$2.00 M (+3.62%)
What is Edwards Lifesciences TTM capital expenditures?
The current TTM CAPEX of EW is $316.30 M
What is the all time high TTM CAPEX for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM capital expenditures is $431.10 M
What is Edwards Lifesciences TTM CAPEX year-on-year change?
Over the past year, EW TTM capital expenditures has changed by +$49.20 M (+18.42%)